Apollo Hospitals announced today that one of its centres in New Delhi, India has become the first hospital in South Asia to introduce the ZAP-X gyroscopic radiosurgery platform (Zap Surgical), describing the event as a “significant milestone”.
The ZAP-X technology introduces a “new era” in brain tumour treatment, offering patients a non-invasive, pain-free alternative with sessions lasting just 30 minutes, according to a press release from the hospital.
“For four decades, Apollo Hospitals has pioneered healthcare, advancing exceptional care,” said Prathap Chandra Reddy, founder chairman of the Apollo Hospitals Group. “We pledge to democratise technology, making it accessible to all citizens and global communities, elevating standards of brain tumour treatment and ensuring better quality of life. ZAP-X strengthens the battle against non-communicable diseases, especially cancers, with superior outcomes.”
The release further notes that ZAP-X “redefines precision” and carries minimal radiation exposure, enabling “new standards in effectiveness and patient comfort”.
Unlike conventional methods, the system utilises a self-shielded, gyroscopic linear accelerator design to direct radiosurgical beams from thousands of potential angles, accurately focusing radiation on the intended tumour or target. Moreover, traditional brain surgeries—typically lasting 3–4 hours, and requiring extended hospitalisation and anaesthesia—are replaced by ZAP-X’s single-session treatment of no more than 30 minutes, facilitating day-care procedures and allowing patients to return home post-treatment.
“Stereotactic radiosurgery is among the most important medical advancements of the past century,” stated John Adler, founder and chief executive officer of Zap Surgical. “Eligible patients no longer must experience debilitating surgical resections, or potentially lose cognitive capacity by undergoing whole-brain radiotherapy. Instead, with ZAP-X radiosurgery, patients can now be quickly treated in an outpatient setting and often return to normal activities the same day with no incisions, and no pain.”
Last month, Zap Surgical also announced the first patient treatment with its ZAP-X system in South Korea. The procedure took place at Dankook University Hospital (DKUH; Cheonan, South Korea), and drew attention from national news outlets.
“The integration of ZAP-X will allow us to deliver state-of-the-art treatment to the patients we serve,” said Lee Sang Koo, vice president of neurosurgery at DKUH.
